Technical Analysis for DXCM - DexCom, Inc.

Grade Last Price % Change Price Change
B 134.72 3.27% 4.26
DXCM closed up 3.27 percent on Monday, March 18, 2024, on 82 percent of normal volume.
8 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Gapped Up Strength 0.00%
NR7 Range Contraction 3.27%
Multiple of Ten Bullish Other 3.27%
Gapped Up Strength 3.27%
Multiple of Ten Bearish Other 4.03%
Overbought Stochastic Strength 4.03%
Upper Bollinger Band Walk Strength 2.31%
Overbought Stochastic Strength 2.31%
180 Bullish Setup Bullish Swing Setup -0.49%
Upper Bollinger Band Walk Strength -0.49%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakout about 15 hours ago
Up 3% about 15 hours ago
Up 1 ATR about 15 hours ago
Up 2% about 15 hours ago
10 DMA Support about 16 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

DexCom, Inc. Description

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Its ambulatory product line includes SEVEN PLUS, DexCom G4 system, and DexCom G4 PLATINUM system for adults with diabetes to detect trends and track glucose patterns, to aid in the detection of hypoglycemia and hyperglycemia, and to facilitate acute and long-term therapy adjustments. The company's in-hospital product line comprises GlucoClear, a blood-based in-vivo automated glucose monitoring system for use by healthcare providers in the hospital. It also offers SweetSpot, a software platform that enables patients to aggregate and analyze data from diabetes devices and to share it with their healthcare providers. The company markets its products directly to endocrinologists, physicians, and diabetes educators primarily in the United States. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: S&P 500 Medicine Nasdaq 100 Diabetes Telehealth Telemedicine Healthcare Providers Software Platform Glucose Platinum Endocrine System Diabetes Mellitus Medical Monitoring Blood Glucose Monitoring Endocrinology Continuous Glucose Monitor Hyperglycemia Glucose Monitoring Systems Hypoglycemia

Is DXCM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 139.53
52 Week Low 74.75
Average Volume 3,237,987
200-Day Moving Average 113.77
50-Day Moving Average 124.22
20-Day Moving Average 124.58
10-Day Moving Average 131.88
Average True Range 4.29
RSI (14) 64.16
ADX 29.76
+DI 30.70
-DI 14.33
Chandelier Exit (Long, 3 ATRs) 125.06
Chandelier Exit (Short, 3 ATRs) 125.92
Upper Bollinger Bands 140.58
Lower Bollinger Band 108.58
Percent B (%b) 0.82
BandWidth 25.68
MACD Line 3.42
MACD Signal Line 2.43
MACD Histogram 0.9924
Fundamentals Value
Market Cap 51.94 Billion
Num Shares 386 Million
EPS 1.30
Price-to-Earnings (P/E) Ratio 103.63
Price-to-Sales 13.52
Price-to-Book 22.45
PEG Ratio 2.46
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 140.83
Resistance 3 (R3) 140.43 138.01 139.81
Resistance 2 (R2) 138.01 136.45 138.20 139.47
Resistance 1 (R1) 136.36 135.49 137.19 136.76 139.13
Pivot Point 133.94 133.94 134.35 134.13 133.94
Support 1 (S1) 132.29 132.38 133.12 132.69 130.31
Support 2 (S2) 129.87 131.42 130.06 129.97
Support 3 (S3) 128.22 129.87 129.63
Support 4 (S4) 128.62